when will semaglutide patent expire Novo Nordisk Braces as Generic Weight Loss Drugs Come to Upend Market

As the patents on semaglutide, a popular diabetes and anti-obesity drug that earned its Danish maker Novo Nordisk nearly USD 30 billion in FY25 alone, expire in nearly 100 countries next year,

21.67

★★★★☆4.8 (126)

Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?

25.36

★★★★★4.9 (98)

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the patent protecting Novo Nordisk's semaglutide expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants,

25.20

★★★★★5.0 (157)

Massive Rs 50,000 Cr Opportunity for Drugmakers as Semaglutide Patents Expire, ETPharma

25.86

★★★★★4.7 (84)

The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in India on March 20, opening the door for a wave of low-cost

28.63

★★★★★4.9 (203)

Semaglutide Generics to Launch in India After Patent Expiry, Prices May Drop 60%

29.37

★★★★★5.0 (176)

Indian companies will soon produce low-cost generic versions of weight-loss drugs like Ozempic, because key patents are set to expire on March 20, expanding access globally. Demand for weight-loss drugs is high

21.87

★★★★★4.8 (132)